MENA Metabolic Conference
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: E-News

E-News

HKU lab

Researchers discover new molecular mechanism in promoting melanoma angiogenesis and metastasis

, 16 May 2022/in E-News /by panglobal

A research team at LKS Faculty of Medicine, The University of Hong Kong (HKUMed) has discovered a new molecular pathway to govern melanoma angiogenesis and metastasis. The findings provide new insights into how melanoma undergoes metastasis and progression through secretion of pro-angiogenic factor to induce angiogenesis that paves the way for new therapeutic opportunities. The […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/05/HKU-lab.jpg 1271 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-05-16 13:03:222022-05-16 13:05:52Researchers discover new molecular mechanism in promoting melanoma angiogenesis and metastasis
ziathpr44

Ziath wins Queen’s Award for Enterprise

, 16 May 2022/in E-News /by panglobal

Ziath has been awarded with a prestigious Queen’s Award for Enterprise (2022) in the International Trade category. 

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/05/ziathpr44.jpg 445 965 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-05-16 12:39:492022-05-16 12:39:49Ziath wins Queen’s Award for Enterprise
proteonic

ProteoNic and NecstGen establish partnership to improve viral vector manufacturing efficiency for gene therapies

, 16 May 2022/in E-News /by panglobal

ProteoNic, a leading provider of premium vector technology and services for efficient production of biologics, and NecstGen, a CDMO and centre of excellence for cell and gene therapy, will partner to improve viral vector manufacturing for gene therapy applications. Both companies, located on the Leiden Bio Science Park, recognise the need to increase viral titres […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/05/proteonic.jpg 537 783 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-05-16 12:38:322022-05-16 12:38:32ProteoNic and NecstGen establish partnership to improve viral vector manufacturing efficiency for gene therapies
vetter xpert alliance

Rentschler Biopharma, Vetter unveil Xpert Alliance, a joint visualization of their collaboration

, 16 May 2022/in E-News /by panglobal

Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), are unveiling Xpert Alliance, a joint visualization of their strategic collaboration. The visualization is designed to “bring to life” this ongoing alliance and celebrate its successful operation, delivering effective solutions to address clients’ changing and expanding needs in the area of complex […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/05/vetter-xpert-alliance-scaled.jpg 1267 2560 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-05-16 12:35:492022-05-16 12:36:35Rentschler Biopharma, Vetter unveil Xpert Alliance, a joint visualization of their collaboration
keen eye ultivue

Keen Eye and Ultivue collaborate to advance multiplex and spatial analysis in clinical research

, 16 May 2022/in E-News /by panglobal

Keen Eye, a leading AI company in digital pathology for clinical research and Ultivue, an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies, will collaborate to promote multiplexed immunofluorescence (mIF) assays and scalable AI applications to unlock spatial analysis in clinical research.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/05/keen_eye-ultivue.jpg 416 576 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-05-16 12:34:082022-05-16 12:34:08Keen Eye and Ultivue collaborate to advance multiplex and spatial analysis in clinical research
horiba QSP

HORIBA introduces network option for digital morphology training tool for multiple user access in multiple locations

, 16 May 2022/in E-News /by panglobal

HORIBA UK has introduced a new network licence option for its QSP 2.0 (Quality Slide Program) [1] affordable digital tool for skill evaluation and training in morphology at IBMS Congress 2022. This now enables up to 50 users across various locations, even in different countries, to directly access this valuable digital morphology resource as it […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/05/horiba_QSP.jpg 853 1280 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-05-16 12:32:332022-05-16 12:32:33HORIBA introduces network option for digital morphology training tool for multiple user access in multiple locations
cytena

CYTENA and ExcellGene to develop automated work-flows for biotherapeutics cell line development

, 16 May 2022/in E-News /by panglobal

CYTENA, a BICO group company and a leading provider of high-precision instruments for handling biological cells, will collaborate with ExcellGene, a leading biologics Contract Development & Manufacturing Organizations (CDMO) that manufactures recombinant proteins, to streamline cell line development workflows for highly-efficient monoclonal antibody (mAb) and complex therapeutic protein manufacturing, which enables important improvements to the […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/05/cytena.png 332 1123 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-05-16 12:29:432022-05-16 12:29:57CYTENA and ExcellGene to develop automated work-flows for biotherapeutics cell line development
codexis seqwell

Codexis and seqWell announce partnership to accelerate commercialization of seqWell’s genomics workflow solutions

, 16 May 2022/in E-News /by panglobal

Codexis and seqWell have announced the initiation of a strategic partnership and investment to accelerate the commercialization of seqWell’s genomics workflow solutions. Codexis, a leading enzyme engineering company enabling the promise of synthetic biology, and seqWell, a developer of transformative library preparation products for demanding genomics applications, plan to collaborate on using Codexis’ CodeEvolver platform […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/05/codexis_seqwell.jpg 542 770 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-05-16 12:27:152022-05-16 12:27:15Codexis and seqWell announce partnership to accelerate commercialization of seqWell’s genomics workflow solutions
biotium 5 22

Biotium acquires CAT5 FFPE RNA/DNA extraction technology from Cell Data Sciences

, 16 May 2022/in E-News /by panglobal

Biotium, a supplier of cutting-edge life science reagents, has acquired Cell Data Sciences RNAstorm and DNAstorm kits for RNA/DNA extraction. Biotium, which previously distributed the Cell Data Sciences kits, will now be their sole manufacturer. The extraction kits will be offered from the Biotium website and authorized distributors.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/05/biotium_5_22.jpg 1920 1280 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-05-16 12:24:522022-05-16 12:24:52Biotium acquires CAT5 FFPE RNA/DNA extraction technology from Cell Data Sciences
Arctoris

Arctoris and Evariste Technologies form a joint venture to identify novel small molecule cMET Inhibitors for Non-Small Cell Lung Cancer

, 16 May 2022/in E-News /by panglobal

Arctoris, a tech-enabled biopharma company, and Evariste Technologies, an AI-drug discovery company, have formed a joint venture to identify novel small molecule kinase inhibitors for treatment of patients with Non-Small Cell Lung Cancer (NSCLC). 

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/05/Arctoris.jpg 540 960 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-05-16 12:22:592022-05-16 12:22:59Arctoris and Evariste Technologies form a joint venture to identify novel small molecule cMET Inhibitors for Non-Small Cell Lung Cancer
Page 59 of 231«‹5758596061›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

March 2026

CLi Cover MRCH 2026
11 March 2026

Isomorphic Labs unveils IsoDDE, a unified AI drug design engine surpassing AlphaFold 3 in biomolecular prediction

11 March 2026

Androgen testing for PCOS diagnosis

9 March 2026

DiaSys Diagnostic Systems | ACE FS

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription